Cpx-351

Cpx-351

AOB17159

CAS 1256639-86-7

More details

1000 Items

$0.00

Overview

Liposomal-encapsulated combination of daunorubicin and cytarabine for the treatment of newly diagnosed tAML or AML with myelodysplasia-related changes (AML-MRCs)